Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NXGL
Upturn stock ratingUpturn stock rating

Nexgel Inc (NXGL)

Upturn stock ratingUpturn stock rating
$2.58
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: NXGL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6

1 Year Target Price $6

Analysts Price Target For last 52 week
$6Target price
Low$1.95
Current$2.58
high$5.1

Analysis of Past Performance

Type Stock
Historic Profit -24.27%
Avg. Invested days 30
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 18.37M USD
Price to earnings Ratio -
1Y Target Price 6
Price to earnings Ratio -
1Y Target Price 6
Volume (30-day avg) 1
Beta 0.52
52 Weeks Range 1.95 - 5.10
Updated Date 06/29/2025
52 Weeks Range 1.95 - 5.10
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.45

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -30.7%
Operating Margin (TTM) -27.69%

Management Effectiveness

Return on Assets (TTM) -20.77%
Return on Equity (TTM) -60.08%

Valuation

Trailing PE -
Forward PE 41.84
Enterprise Value 20150524
Price to Sales(TTM) 1.8
Enterprise Value 20150524
Price to Sales(TTM) 1.8
Enterprise Value to Revenue 1.97
Enterprise Value to EBITDA -0.85
Shares Outstanding 7654540
Shares Floating 6447417
Shares Outstanding 7654540
Shares Floating 6447417
Percent Insiders 16.2
Percent Institutions 8.56

Analyst Ratings

Rating 1
Target Price 6
Buy 1
Strong Buy -
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Nexgel Inc

stock logo

Company Overview

overview logo History and Background

Nexgel, Inc. was founded to develop and commercialize advanced hydrogels for various applications. While specific founding year and early milestones are unavailable from public sources, the company has focused on developing proprietary hydrogel technology for consumer and healthcare markets.

business area logo Core Business Areas

  • Advanced Hydrogels: Develops and manufactures advanced hydrogels, focusing on performance and skin health.
  • Consumer Healthcare: Creates and markets hydrogel-based products in the consumer healthcare space, including skincare and wound care.
  • Private Label Manufacturing: Offers private label manufacturing services for other companies seeking to incorporate hydrogel technology into their products.

leadership logo Leadership and Structure

Public information on Nexgel Inc.'s leadership and organizational structure is limited, hindering a full detailed description.

Top Products and Market Share

overview logo Key Offerings

  • Hydra-Lock Moisturizing Gel: A flagship product designed for superior moisturization and skin hydration. Market share data is not publicly available. Competitors include Neutrogena Hydro Boost, and other major skincare brands offering hydrating gels and creams. Revenue and number of users is not publicly available.
  • Advanced Wound Care Gel: A hydrogel-based wound care product designed to promote healing and reduce scarring. Market share data is not publicly available. Competitors include Curad, Band-Aid, and other brands providing wound care solutions. Revenue and number of users is not publicly available.

Market Dynamics

industry overview logo Industry Overview

The advanced hydrogel market is growing, driven by increasing demand in healthcare, cosmetics, and other applications. Factors like aging populations, increasing awareness of advanced wound care, and rising demand for advanced skincare solutions are driving the market. However, there is fierce competition among brands already in the market, and this competition may be a factor in the company's recent underperformance.

Positioning

Nexgel positions itself as an innovator in advanced hydrogel technology, aiming to create high-performance products for consumer healthcare and private label partners. Nexgel is focused on skin health and enhanced product performance via its hydrogels.

Total Addressable Market (TAM)

The global hydrogel market is estimated to reach billions of dollars. Nexgel is positioned to capture a share of this market by focusing on niche applications with its hydrogel technology. The TAM is large but Nexgel's current market share is small, providing opportunity for growth if they are able to capture market share.

Upturn SWOT Analysis

Strengths

  • Proprietary hydrogel technology
  • Focus on skin health and enhanced product performance
  • Potential for private label manufacturing partnerships
  • Innovative formulations

Weaknesses

  • Limited brand recognition compared to established players
  • Restricted financial resources compared to larger competitors
  • Dependence on private label manufacturing success
  • Lack of information available on key metrics like Revenue, market share, number of users, etc

Opportunities

  • Expanding into new product categories (e.g., sun care, anti-aging)
  • Securing strategic partnerships with larger healthcare or consumer goods companies
  • Leveraging e-commerce channels for direct-to-consumer sales
  • Growing applications in the wound care sector

Threats

  • Intense competition from established players with greater resources
  • Changes in consumer preferences and market trends
  • Regulatory hurdles and compliance costs
  • Potential for technological obsolescence

Competitors and Market Share

competitor logo Key Competitors

  • JNJ
  • NSRGY
  • UNVRF

Competitive Landscape

Nexgel's competitive advantages stem from its proprietary hydrogel technology. However, its size and brand recognition are significant disadvantages compared to larger competitors like Johnson & Johnson (JNJ) and Nestle (NSRGY).

Growth Trajectory and Initiatives

Historical Growth: Historical growth is unknown due to the lack of financial data.

Future Projections: Future growth projections are unavailable due to the lack of analyst estimates.

Recent Initiatives: Recent strategic initiatives may include new product launches or new partnerships, but it is not possible to assess without further information.

Summary

Nexgel is a small company with innovative hydrogel technology but faces significant competition. Their strength lies in their proprietary formulations, however their lack of financial backing and limited market presence pose major challenges. To improve, Nexgel needs to find additional ways to generate revenue. If they can, this will turn Nexgel into a successful company.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company press releases
  • Industry reports
  • Publicly available information
  • Analyst reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data is estimated and may not be precise. Financial data is incomplete and requires further data to be complete.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Nexgel Inc

Exchange NASDAQ
Headquaters Langhorne, PA, United States
IPO Launch date 2021-12-22
CEO, President & Director Mr. Adam R. Levy
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 19
Full time employees 19

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.